Organization
University of Leicester and Leicester University Hospitals
6 abstracts
Abstract
Efficacy, cellular and molecular determinants of PD-1 checkpoint inhibition in relapsed mesothelioma.Org: University of Leicester and Leicester University Hospitals, University of Southampton, Harry Perkins Institute of Medical Research, Perth, Australia, Liverpool, United Kingdom,
Abstract
EZH2/EZH1 inhibitor tulmimetostat (CPI-0209) in patients with advanced solid tumors or hematologic malignancies: Preliminary phase II results.Org: Swedish Cancer Institute, University of Leicester and Leicester University Hospitals, University Hospitals Of Leicester NHS Trust, Service d'hématologie clinique du CHU de Nantes, START Midwest, Grand Rapids, MI,
Abstract
A gut microbiota rheostat to forecast response to PDL1-VEGF blockade in mesothelioma.Org: University of Leicester and Leicester University Hospitals, Leicester University Hospitals, Harry Perkins Institute of Medical Research, The University of Western Australia Centre for Medical Research, Leicester Royal Infirmary,
Abstract
A randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO.Org: Cancer Research UK Clinical Trials Unit, University of Southampton, University of Leicester and Leicester University Hospitals, Southampton Clinical Trials Unit, University Hospital Southampton NHS Foundation Trust,
Abstract
Bemcentinib and pembrolizumab in patients with relapsed mesothelioma: MIST3, a phase IIa trial with cellular and molecular correlates of efficacy.Org: The University of Manchester and The Christie NHS Foundation Trust, University of Leicester and Leicester University Hospitals, University Hospitals Of Leicester NHS Trust, Northern Centre for Cancer Care, University of Newcastle, The Newcastle upon Tyne Hospitals NHS Foundation Trust,
Abstract
ASSOCIATION BETWEEN ETHNICITY AND INITIAL RESPONSE TO TNF INHIBITORS IN PEOPLE WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER FOR RHEUMATOID ARTHRITIS (BSRBR-RA)Org: The University of Manchester and The Christie NHS Foundation Trust, Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Oxford University Hospitals NHS FT,